Last update 24 Mar 2025

NHWD-870

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NHWD 870, NHWD-870 HCl, WD-870
Target
Action
inhibitors
Mechanism
BET inhibitors(Bromodomain and extra terminal domain protein inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC29H29N7O
InChIKeyBBKUPPVLTRGWDN-GDLZYMKVSA-N
CAS Registry2115742-04-4

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
China
25 Apr 2024
Advanced NUT CarcinomaPhase 2
China
25 Apr 2024
Diffuse Large B-Cell LymphomaPhase 2
China
26 Oct 2023
Non-Hodgkin LymphomaPhase 2--
NUT midline carcinomaPhase 2--
Diffuse large B-cell lymphoma refractoryPhase 1
China
29 Jan 2021
Disseminated diffuse large B-cell lymphomaPhase 1
China
29 Jan 2021
Follicular LymphomaPhase 1
China
29 Jan 2021
Melanoma, Cutaneous MalignantPhase 1
China
29 Jan 2021
Mucosal MelanomaPhase 1
China
29 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
gqvbbdgmdh(svqphnsbub) = eragkonkea zgvrynzpro (arxiwxkbfz )
-
17 Oct 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free